or
forgot password

    • cancer clinical trials in chattanooga, TN

    • Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Erlanger Health System
    Chattanooga, Tennessee 37403
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Chattanooga, Tennessee
    Non-Hodgkin's Lymphoma
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Chattanooga Oncology & Hematology Associates, P.C.

    Trial Locations
    Chattanooga Oncology & Hematology Associates, P.C.
    Memorial Hospital
    Ovarian Neoplasms
    Phase II CT-2103/Carboplatin in Ovarian Cancer
    Chattanooga GYN-Oncology
    Chattanooga, Tennessee 37403
    Ovarian Neoplasm
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Lymphoma
    MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer
    Associates in Oncology and Hematology
    Chattanooga, Tennessee 37404
    Prostate Cancer
    CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
    Research Site
    Chattanooga, Tennessee
    Prostatic Neoplasms
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Iressa Versus Docetaxel (Taxotere)
    Research Site
    Chattanooga, Tennessee
    Non-Small-Cell Lung Carcinoma
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    T.C. Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    Brain and Central Nervous System Tumors
    Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)
    Local Institution
    Chattanooga, Tennessee
    Breast Cancer, Metastases
    Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
    Local Institution
    Chattanooga, Tennessee
    Breast Cancer, Metastases
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Memorial Hospital

    Trial Locations
    Memorial Hospital
    Chattanooga Oncology & Hemtology Associates, P. C.
    Non Small Cell Lung Carcinoma
    Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Leukemia
    Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    Chattanooga GYN Oncology
    Chattanooga, Tennessee 37403
    Ovarian Cancer, Primary Peritoneal Carcinoma
    CP-675,206 In Patients With Advanced Melanoma
    Research Site
    Chattanooga, Tennessee
    Malignant Melanoma
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Chattanooga, Tennessee
    Colorectal Cancer, Metastases
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Chattanooga, Tennessee
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    Non-small Cell Lung Cancer Registry
    Associates in Oncology and Hematology
    Chattanooga, Tennessee 37404
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
    Local Institution
    Chattanooga, Tennessee
    Non-small Cell Lung Cancer
    Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
    Local Institution
    Chattanooga, Tennessee
    Chronic Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-positive
    Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
    Local Institution
    Chattanooga, Tennessee
    Transitional Cell Carcinoma, Bladder Neoplasms, Kidney Neoplasms, Ureter Neoplasms, Bladder Cancer, Neoplasm, Bladder
    Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
    Local Institution
    Chattanooga, Tennessee
    Chronic Myelogenous Leukemia
    Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
    Local Institution
    Chattanooga, Tennessee
    Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia
    TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer
    Parkridge Medical Center

    Trial Locations
    Parkridge Medical Center
    Chattanooga GYN Oncology
    Baroness Erlander Hospital
    Ovarian Neoplasms
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Cancer Center at Erlanger Health
    Chattanooga, Tennessee 37403
    Breast Cancer
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Colon Cancer
    Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Neoplasms, Unknown Primary
    An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer
    Local Institution
    Chattanooga, Tennessee
    Metastatic Colorectal Cancer
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Chattanooga, Tennessee
    Diabetes Mellitus, Type 2
    Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer
    Chattanooga Oncology & Hematology Associates, PC
    Chattanooga, Tennessee 37404
    Breast Neoplasm
    Study of CP-675,206 in Refractory Melanoma
    Research Site
    Chattanooga, Tennessee
    Refractory Melanoma
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Chattanooga GYN Oncology
    Chattanooga, Tennessee 37403
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Neoplasms
    Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
    Associates in Hematology Oncology
    Chattanooga, Tennessee 37404
    Breast Neoplasms, Breast Cancer
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Associates in Oncology and Hematology
    Chattanooga, Tennessee 37404
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Small Cell Lung Cancer, Carcinoma, Small Cell
    Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Carcinoma, Small Cell Lung
    Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
    Chattanooga Oncology and Hematology Associates
    Chattanooga, Tennessee 37404
    Breast Cancer
    A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
    Local Institution
    Chattanooga, Tennessee
    Leukemia, Myeloid, Chronic, Leukemia, Lymphocytic, Acute, L2
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Associates in Hematology Oncology
    Chattanooga, Tennessee 37404
    Carcinoma, Small Cell
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Carcinoma, Small Cell Lung, Lung Cancer
    Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
    Chattanooga Oncology Hematology Associates
    Chattanooga, Tennessee 37404
    Neoplasm, Unknown Primary
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    T C Thompson Children's Hospital
    Chattanooga, Tennessee 37403
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
    Chattanooga GYN Oncology

    Trial Locations
    Chattanooga GYN Oncology
    Chattanooga's Program in Women's Oncology
    Fallopian Tube Cancer, Peritoneal Neoplasms, Ovarian Cancer